Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Miguel Angel Merlos Rodrigo, Simona Dostalova, Hana Buchtelova, Vladislav Strmiska, Petr Michalek, Sona Krizkova, Ales Vicha, Pavla Jencova, Tomas Eckschlager, Marie Stiborova, Zbynek Heger, Vojtech Adam
Published Dec 16, 2017 · Vol. 9, No. 4 · pp. 4427-4439
Shalin Shah, Kevin Wood, Brian Labadie, Brian Won, Ryan Brisson, Theodore Karrison, Thomas Hensing, Mark Kozloff, Riyue Bao, Jyoti D. Patel, Jason J. Luke
Published Dec 15, 2017 · Vol. 9, No. 4 · pp. 4375-4384
Sherise D. Ferguson, Shouhao Zhou, Joanne Xiu, Yuuri Hashimoto, Nader Sanai, Lyndon Kim, Santosh Kesari, John de Groot, David Spetzler, Amy B. Heimberger
Published Dec 15, 2017 · Vol. 9, No. 8 · pp. 7822-7831